How to buy Generation Bio Co stock (GBIO)

Generation Bio Co is a biotechnology business based in the US. Generation Bio Co shares (GBIO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.07 – an increase of 4.9% over the previous week. Generation Bio Co employs 174 staff and has a trailing 12-month revenue of around $18.6 million.

Our top picks for where to buy Generation Bio Co stock

Buy Generation Bio Co stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Generation Bio Co stock price (NASDAQ: GBIO)

Use our graph to track the performance of GBIO stocks over time.

Generation Bio Co shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$1.07
52-week range	$0.75 - $4.65
50-day moving average more info button	$1.85
200-day moving average more info button	$2.68
Wall St. target price	$7.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-2.19

Is it a good time to buy Generation Bio Co stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Generation Bio Co price performance over time

Historical closes compared with the close of $1.1 from 2024-12-23

1 week (2024-12-18)	7.84%
1 month (2024-11-25)	-21.43%
3 months (2024-09-25)	-56.69%
6 months (2024-06-25)	-61.13%

1 year (2023-12-22)	-42.41%
2 years (2022-12-23)	-73.87%
3 years (2021-12-23)	8.2
5 years (2019-12-21)	N/A

Generation Bio Co financials

Revenue TTM	$18.6 million
Gross profit TTM	$0
Return on assets TTM	-19.29%
Return on equity TTM	-86.5%
Profit margin	0%
Book value	$1.57
Market Capitalization more info button	$68.1 million

TTM: trailing 12 months

Generation Bio Co share dividends

We're not expecting Generation Bio Co to pay a dividend over the next 12 months.

Generation Bio Co share price volatility

Over the last 12 months, Generation Bio Co's shares have ranged in value from as little as $0.75 up to $4.65. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Generation Bio Co's is 2.818. This would suggest that Generation Bio Co's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Generation Bio Co overview

Generation Bio Co. develops non-viral genetic medicines for the treatment of rare and prevalent diseases. The company develops cell-targeted lipid nanoparticle (ctLNP) platform, a modular delivery system for nucleic acids to avoid off-target clearance by the liver and spleen that enables ctLNPs to persist in systemic circulation, which allows for highly selective and potent ligand-driven targeting to specific tissues and cell types; and novel immune-quiet DNA (iqDNA) to enable long-lasting high levels of gene expression from non-integrating episomes and avoids innate immune sensors that have long prevented DNA from use in non-viral systems. It uses its platform for developing a portfolio of programs for treating cancer, autoimmune, hematologic disorders, prioritizing sickle cell, beta-thalassemia, and hemophilia A diseases, as well as for other tissues and cell types, including retina, skeletal muscle, and central nervous system. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017.

Frequently asked questions

null
What percentage of Generation Bio Co is owned by insiders or institutions?
Currently 14.514% of Generation Bio Co shares are held by insiders and 82.938% by institutions. How many people work for Generation Bio Co?
Latest data suggests 174 work at Generation Bio Co. When does the fiscal year end for Generation Bio Co?
Generation Bio Co's fiscal year ends in December. Where is Generation Bio Co based?
Generation Bio Co's address is: 301 Binney Street, Cambridge, MA, United States, 02142 What is Generation Bio Co's ISIN number?
Generation Bio Co's international securities identification number is: US37148K1007